Phosphinate peptide analogs for the treatment of fibrotic disorders

US6750202B1 · kind B1 · utility

Assignee

• Elmar R. Burchardt · DE

Inventors

• Elmar Burchardt · Wuppertal, DE
• Michael Schauer · Wuppertal, DE
• Walter Stöcker · Nottuln, DE
• Thomas Lampe · Mülheim an der Ruhr, DE

Key dates

• Filing date: Jun 21, 2001
• Grant date: Jun 15, 2004
• Expiry date: Jun 21, 2021

Classification

• Technology area (CPC A): Human Necessities
• CPC primary: A61P43/00
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

The invention relates to a method of treating a fibrotic disease, comprising administering to a mammal an effective amount of a phospinate-peptide analog of the general formula (I).